Journal
EBIOMEDICINE
Volume 2, Issue 7, Pages 755-764Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ebiom.2015.05.027
Keywords
Lupus; Neuropsychiatric lupus; CA1 place cell; Hippocampus; Mouse lupus model
Funding
- NIH [P01-AI073693, P01-AI102852]
Ask authors/readers for more resources
Patients with systemic lupus erythematosus (SLE) experience cognitive abnormalities in multiple domains including processing speed, executive function, and memory. Here we show that SLE patients carrying antibodies that bind DNA and the GluN2A and GluN2B subunits of the N-methyl-D-aspartate receptor (NMDAR), termed DNRAbs, displayed a selective impairment in spatial recall. Neural recordings in a mouse model of SLE, in which circulating DNRAbs penetrate the hippocampus, revealed that CA1 place cells exhibited a significant expansion in place field size. Structural analysis showed that hippocampal pyramidal cells had substantial reductions in their dendritic processes and spines. Strikingly, these abnormalities became evident at a time when DNRAbs were no longer detectable in the hippocampus. These results suggest that antibody-mediated neurocognitive impairments may be highly specific, and that spatial cognition may be particularly vulnerable to DNRAb-mediated structural and functional injury to hippocampal cells that evolves after the triggering insult is no longer present. (C) 2015 The Authors. Published by Elsevier B. V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available